loadpatents
name:-0.098100185394287
name:-0.017627000808716
name:-0.035125970840454
ZETSCHE; Bernd Patent Filings

ZETSCHE; Bernd

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZETSCHE; Bernd.The latest application filed is for "compositions and methods for treating hemoglobinopathies".

Company Profile
24.12.38
  • ZETSCHE; Bernd - Cambridge MA
  • Zetsche; Bernd - Gloucester MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods For Treating Hemoglobinopathies
App 20220235347 - SLAYMAKER; Ian ;   et al.
2022-07-28
Novel Crispr Enzymes And Systems
App 20220195503 - ZHANG; Feng ;   et al.
2022-06-23
Adenosine Deaminase Base Editors And Methods Of Using Same To Modify A Nucleobase In A Target Sequence
App 20220170027 - GAUDELLI; Nicole ;   et al.
2022-06-02
Compositions and methods for treating hemoglobinopathies
Grant 11,344,609 - Slaymaker , et al. May 31, 2
2022-05-31
Cpf1 Complexes With Reduced Indel Activity
App 20220162584 - Zhang; Feng ;   et al.
2022-05-26
Compositions And Methods For Treating Glycogen Storage Disease Type 1a
App 20220127594 - GAUDELLI; Nicole ;   et al.
2022-04-28
Splice Acceptor Site Disruption Of A Disease-associated Gene Using Adenosine Deaminase Base Editors, Including For The Treatment Of Genetic Disease
App 20220098593 - GAUDELLI; Nicole ;   et al.
2022-03-31
Cpf1 complexes with reduced indel activity
Grant 11,286,478 - Zhang , et al. March 29, 2
2022-03-29
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
Grant 11,155,803 - Gaudelli , et al. October 26, 2
2021-10-26
CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes
Grant 11,149,259 - Zhang , et al. October 19, 2
2021-10-19
Nucleic Acid Assemblies For Use In Targeted Delivery
App 20210317479 - Zhang; Feng ;   et al.
2021-10-14
Compositions and methods for treating hemoglobinopathies
Grant 11,142,760 - Slaymaker , et al. October 12, 2
2021-10-12
Compositions And Methods For Treating Hemoglobinopathies
App 20210261955 - SLAYMAKER; Ian ;   et al.
2021-08-26
Compositions And Methods For Treating Hemoglobinopathies
App 20210252118 - SLAYMAKER; Ian ;   et al.
2021-08-19
CRISPR enzymes and systems
Grant 11,091,798 - Zhang , et al. August 17, 2
2021-08-17
Crispr-cas Systems Having Destabilization Domain
App 20210222164 - CHOUDHARY; Amit ;   et al.
2021-07-22
Novel Crispr Enzymes And Systems
App 20210155911 - ZHANG; Feng ;   et al.
2021-05-27
Crispr Having Or Associated With Destabilization Domains
App 20210139872 - ZHANG; Feng ;   et al.
2021-05-13
Adenosine Deaminase Base Editors And Methods Of Using Same To Modify A Nucleobase In A Target Sequence
App 20210130805 - GAUDELLI; Nicole ;   et al.
2021-05-06
Crispr Effector System Based Multiplex Diagnostics
App 20210108267 - Zhang; Feng ;   et al.
2021-04-15
Cas12a Systems, Methods, And Compositions For Targeted Rna Base Editing
App 20210079366 - Zhang; Feng ;   et al.
2021-03-18
Cas12b Systems, Methods, And Compositions For Targeted Rna Base Editing
App 20210071163 - Zhang; Feng ;   et al.
2021-03-11
Novel Crispr Enzymes And Systems
App 20210040546 - ZHANG; Feng ;   et al.
2021-02-11
Crispr enzyme mutations reducing off-target effects
Grant 10,876,100 - Zhang , et al. December 29, 2
2020-12-29
Novel Crispr Enzymes And Systems
App 20200392473 - Zhang; Feng ;   et al.
2020-12-17
Novel Crispr Enzymes And Systems
App 20200318173 - ZHANG; Feng ;   et al.
2020-10-08
Novel Crispr Enzymes And Systems
App 20200318172 - ZHANG; Feng ;   et al.
2020-10-08
Systems, Methods, And Compositions For Targeted Nucleic Acid Editing
App 20200283755 - Zhang; Feng ;   et al.
2020-09-10
Novel Crispr Enzymes And Systems
App 20200263190 - Zhang; Feng ;   et al.
2020-08-20
Cpf1 Complexes With Reduced Indel Activity
App 20200263166 - ZHANG; Feng ;   et al.
2020-08-20
CRISPR enzymes and systems
Grant 10,669,540 - Zhang , et al.
2020-06-02
CRISPR enzymes and systems
Grant 10,648,020 - Zhang , et al.
2020-05-12
Crispr Enzyme Mutations Reducing Off-target Effects
App 20200087641 - ZHANG; Feng ;   et al.
2020-03-19
Crispr enzyme mutations reducing off-target effects
Grant 10,494,621 - Zhang , et al. De
2019-12-03
Crispr-cas Systems And Methods For Altering Expression Of Gene Products, Structural Information And Inducible Modular Cas Enzyme
App 20190330605 - Zhang; Feng ;   et al.
2019-10-31
Crystal Structure Of Crispr Cpf1
App 20190264186 - Yamano; Takashi ;   et al.
2019-08-29
Novel Crispr Enzymes And Systems
App 20190256900 - ZHANG; Feng ;   et al.
2019-08-22
CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymes
Grant 10,377,998 - Zhang , et al. A
2019-08-13
Novel Crispr Enzymes And Systems
App 20190233814 - ZHANG; Feng ;   et al.
2019-08-01
Novel Crispr Enzymes And Systems
App 20190218602 - ZHANG; Feng ;   et al.
2019-07-18
Novel Crispr Enzymes And Systems
App 20190071717 - Zhang; Feng ;   et al.
2019-03-07
Crispr Enzyme Mutations Reducing Off-target Effects
App 20190032036 - ZHANG; Feng ;   et al.
2019-01-31
Crispr Enzyme Mutations Reducing Off-target Effects
App 20190010471 - Zhang; Feng ;   et al.
2019-01-10
Novel Crispr Enzymes And Systems
App 20180155716 - Zhang; Feng ;   et al.
2018-06-07
Crispr-cas Systems And Methods For Altering Expression Of Gene Products, Structural Information And Inducible Modular Cas Enzymes
App 20180066242 - Zhang; Feng ;   et al.
2018-03-08
Crispr Having Or Associated With Destabilization Domains
App 20170306307 - Zhang; Feng ;   et al.
2017-10-26
CRISPR enzymes and systems
Grant 9,790,490 - Zhang , et al. October 17, 2
2017-10-17
Novel Crispr Enzymes And Systems
App 20160208243 - Zhang; Feng ;   et al.
2016-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed